Forskning ved Københavns Universitet - Københavns Universitet

Forside

Authors' reply: efficacy and safety of the weight-loss drug rimonabant

Publikation: Bidrag til tidsskriftKommentar/debatForskning

Standard

Authors' reply : efficacy and safety of the weight-loss drug rimonabant. / Astrup, Arne; Christensen, Robin; Bartels, Else Marie; Bliddal, Henning.

I: Lancet, Bind 371, 2008, s. 556-557.

Publikation: Bidrag til tidsskriftKommentar/debatForskning

Harvard

Astrup, A, Christensen, R, Bartels, EM & Bliddal, H 2008, 'Authors' reply: efficacy and safety of the weight-loss drug rimonabant', Lancet, bind 371, s. 556-557.

APA

Astrup, A., Christensen, R., Bartels, E. M., & Bliddal, H. (2008). Authors' reply: efficacy and safety of the weight-loss drug rimonabant. Lancet, 371, 556-557.

Vancouver

Astrup A, Christensen R, Bartels EM, Bliddal H. Authors' reply: efficacy and safety of the weight-loss drug rimonabant. Lancet. 2008;371:556-557.

Author

Astrup, Arne ; Christensen, Robin ; Bartels, Else Marie ; Bliddal, Henning. / Authors' reply : efficacy and safety of the weight-loss drug rimonabant. I: Lancet. 2008 ; Bind 371. s. 556-557.

Bibtex

@article{ea53ad70a1c311ddb6ae000ea68e967b,
title = "Authors' reply: efficacy and safety of the weight-loss drug rimonabant",
author = "Arne Astrup and Robin Christensen and Bartels, {Else Marie} and Henning Bliddal",
year = "2008",
language = "English",
volume = "371",
pages = "556--557",
journal = "Lancet",
issn = "0140-6736",
publisher = "TheLancet Publishing Group",

}

RIS

TY - JOUR

T1 - Authors' reply

T2 - efficacy and safety of the weight-loss drug rimonabant

AU - Astrup, Arne

AU - Christensen, Robin

AU - Bartels, Else Marie

AU - Bliddal, Henning

PY - 2008

Y1 - 2008

M3 - Comment/debate

VL - 371

SP - 556

EP - 557

JO - Lancet

JF - Lancet

SN - 0140-6736

ER -

ID: 8105568